Gamesquare Holdings Inc is a media and entertainment company that focuses on the rapidly growing esports and gaming industry
The company operates through various subsidiaries and is involved in a range of activities, including creating and managing esports teams, developing content, and providing marketing services tailored to gamers and esports fans. Through innovative partnerships and strategic investments, Gamesquare aims to connect brands with the youth culture of gaming, enhancing fan experiences and driving engagement within the competitive gaming landscape.
GameSquare made a company-changing acquisition that has already paid for itself multiple times over through sales of parts, $18M in cost-cutting, and a flurry of deals. It's speeding towards being cash flow positive. The shares are cheap.
GameSquare recently released some impressive numbers, following a potentially game-changing acquisition. We took a deep dive into the company, including an exclusive interview with its CEO, Justin Kenna.
FaZe Holdings announced plans for "FaZe Fridays" to continue throughout 2024 after seeing strong viewership and engagement numbers in the first four events. The live event series created for gamers, by gamers will award over $1 million in cash prizes throughout the year.
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.46% to 34,259.45 while the NASDAQ fell 0.11% to 13,801.13. The S&P 500, also fell, dropping, 0.23% to 4,445.15.
Gainers Allarity Therapeutics, Inc. (NASDAQALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in DRP-selected metastatic breast cancer patients.
Gainers Versus Systems Inc. (NASDAQVS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit management.
Companies Reporting Before The Bell • Goldman Sachs Group (NYSEGS) is projected to report quarterly earnings at $5.48 per share on revenue of $10.83 billion.
Gainers Vallon Pharmaceuticals, Inc. (NASDAQVLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
